Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Pudendal Neuralgia

ClinicalTrials.gov lists 18 trials for Pudendal Neuralgia or a narrower condition beneath it.

MeSH D060545 Nervous System Diseases C10 C23 Listed by Orphanet as a rare disease
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Phase 2 Phase 2 1 Phase 3 Phase 3 1 Phase 4 Phase 4 2 Not applicable Not applicable 8 Observational Observational 6 Phase 2 Phase 2 1 Phase 3 Phase 3 1 Phase 4 Phase 4 2 Not applicable Not applicable 8 Observational Observational 6

Trials per phase

18 of the 18 trials are tagged with Pudendal Neuralgia itself; the rest are tagged with a narrower condition beneath it.

Get the Pudendal Neuralgia report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Pudendal Neuralgia trials start? (10)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials over time, by phase

  • Phase 2
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational

Top of scale: 3

2008: 1 trials (Phase 4 1) 2010: 1 trials (Phase 2 1) 2015: 1 trials (Not applicable 1) 2016: 1 trials (Observational 1) 2018: 1 trials (Not applicable 1) 2019: 3 trials (Observational 1, Not applicable 2) 2022: 1 trials (Not applicable 1) 2023: 3 trials (Not applicable 2, Phase 3 1) 2024: 3 trials (Observational 2, Phase 4 1) 2025: 3 trials (Observational 2, Not applicable 1)

Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2025 3
2024 3
2023 3
2022 1
2019 3
2018 1
2016 1
2015 1
2010 1
2008 1

No forecast is made for this condition: it averages 2.0 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: none of the 18 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Pudendal Neuralgia trials in? (5)

Shown in this order: phase order.

Show the trials by phase as a table
Trials by phase
Phase Trials
Phase 2 1
Phase 3 1
Phase 4 2
Not applicable 8
Observational 6

How many Pudendal Neuralgia trials are recruiting? (3)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Recruiting 6
Completed 8
Unknown status 4

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which drugs are being tested for Pudendal Neuralgia? (1)

Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.

Drugs tested
Drug Trials
+/- Bupivacaine HCl 1

Interventions as named in the registry (10)

Shown in this order: most trials first.

Interventions as named in the registry
Drug Trials
Physiological serum 1
NaCl 0.9% NS 1
Lidocaine Injectable Solution 1
type A botulinum toxin 1
Depmedrol 1

These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.

Which publications cover Pudendal Neuralgia? (13)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Prevalence (6)

Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.

Prevalence
Orphanet disease Type Class Geography Jurisdiction Mapping relation
Pudendal nerve entrapment syndrome Point prevalence Unknown Worldwide Not stated Unspecified
Pudendal nerve entrapment syndrome Point prevalence 1-5 / 10 000 France Not stated Exact
Pudendal nerve entrapment syndrome Point prevalence Unknown Worldwide Not stated Exact
Pudendal nerve entrapment syndrome Point prevalence 1-5 / 10 000 France Not stated Unspecified
Pudendal nerve entrapment syndrome Point prevalence 1-5 / 10 000 France Not stated Exact

Rare-disease identity (2)

Shown in this order: exact, broader, narrower, other.

Rare-disease identity
Orphanet disease ORPHA code Relation Source
Pudendal nerve entrapment syndrome 60039 Exact Orphadata Science knowledge files, Product 1
Pudendal nerve entrapment syndrome 60039 Exact Orphanet Rare Disease Ontology (ORDO)

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, and sub-conditions in mesh.

Browse all condition evidence pages